1. Home
  2. ROIV vs CRDO Comparison

ROIV vs CRDO Comparison

Compare ROIV & CRDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

N/A

Current Price

$35.74

Market Cap

28.7B

Sector

Health Care

ML Signal

N/A

Logo Credo Technology Group Holding Ltd

CRDO

Credo Technology Group Holding Ltd

N/A

Current Price

$208.62

Market Cap

50.7B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
ROIV
CRDO
Founded
2014
2008
Country
United Kingdom
Cayman Islands
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
28.7B
50.7B
IPO Year
2021
2022

Fundamental Metrics

Financial Performance
Metric
ROIV
CRDO
Price
$35.74
$208.62
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
13
19
Target Price
$48.08
★ $280.10
AVG Volume (30 Days)
6.9M
★ 8.3M
Earning Date
11-09-2026
09-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 765.52
EPS
N/A
★ 0.67
Revenue
$8,260,000.00
★ $1,335,116,000.00
Revenue This Year
$530.75
$87.36
Revenue Next Year
$685.92
$54.96
P/E Ratio
★ N/A
$288.95
Revenue Growth
N/A
★ 205.68
52 Week Low
$15.25
$86.49
52 Week High
$42.50
$308.67

Technical Indicators

Market Signals
Indicator
ROIV
CRDO
Relative Strength Index (RSI) 46.25 52.72
Support Level $33.15 $181.43
Resistance Level $37.59 $210.97
Average True Range (ATR) 1.21 8.98
MACD -0.40 4.72
Stochastic Oscillator 22.31 76.40

Price Performance

Historical Comparison
ROIV
CRDO

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

About CRDO Credo Technology Group Holding Ltd

Credo Technology Group Holding Ltd provides connectivity solutions for AI-driven applications, cloud computing, and hyperscale networks. Its high-speed copper and optical interconnect products support data infrastructure demands. The Company's product portfolio includes ZeroFlap (ZF) Active Electrical Cables (AECs), ZF optical transceivers, OmniConnect memory solutions, and retimers and DSPs for optical and copper Ethernet and PCIe, leveraging the PILOT diagnostic and analytics software platform. Its products are based on Serializer/Deserializer (SerDes) and Digital Signal Processor (DSP) technologies and include integrated circuits (ICs), Active Electrical Cables (AECs), SerDes Chiplets, and SerDes IP licensing solutions. The United States generates the maximum revenue.

Share on Social Networks: